Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Catalyst Pharmaceuticals (CPRX) Operating Leases (2019 - 2026)

Catalyst Pharmaceuticals filings provide 8 years of Operating Leases readings, the most recent being $2.2 million for Q1 2026.

  • On a quarterly basis, Operating Leases fell 16.64% to $2.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.2 million, a 16.64% decrease, with the full-year FY2025 number at $2.4 million, down 15.65% from a year prior.
  • Operating Leases hit $2.2 million in Q1 2026 for Catalyst Pharmaceuticals, down from $2.4 million in the prior quarter.
  • In the past five years, Operating Leases ranged from a high of $4.1 million in Q1 2022 to a low of $2.2 million in Q1 2026.
  • Median Operating Leases over the past 5 years was $3.1 million (2024), compared with a mean of $3.1 million.
  • Biggest five-year swings in Operating Leases: changed 0.0% in 2022 and later dropped 17.39% in 2023.
  • Catalyst Pharmaceuticals' Operating Leases stood at $3.6 million in 2022, then fell by 10.37% to $3.2 million in 2023, then decreased by 12.61% to $2.8 million in 2024, then fell by 15.65% to $2.4 million in 2025, then decreased by 4.89% to $2.2 million in 2026.
  • The last three reported values for Operating Leases were $2.2 million (Q1 2026), $2.4 million (Q4 2025), and $2.5 million (Q3 2025) per Business Quant data.